6896.HK
Golden Throat Holdings Group Company Limited [6896.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6896.HK Stock Summary
Top 10 Correlated ETFs
6896.HK
Top 10 Correlated Stocks
6896.HK
In the News
6896.HK Financial details
Company Rating
Strong Buy
Market Cap
1.88B
Income
151.26M
Revenue
771.4M
Book val./share
-
Cash/share
-
Dividend
0.36
Dividend %
14.54%
Employees
860
Optionable
No
Shortable
Yes
Earnings
25 Aug 2023
P/E
6.51
Forward P/E
-
PEG
-3.59
P/S
1.85
P/B
1.19
P/C
-
P/FCF
7.17
Quick Ratio
1.26
Current Ratio
2.44
Debt / Equity
0.18
LT Debt / Equity
-
-
-
EPS (TTM)
0.2
EPS next Y
-
EPS next Q
-
EPS this Y
52%
EPS next Y
-
EPS next 5Y
53.73%
EPS last 5Y
22.1%
Revenue last 5Y
7.4%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
50%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
12%
ROE
19%
ROC
0.25%
Gross Margin
73%
Oper. Margin
39%
Profit Margin
28%
Payout
40%
Shs Outstand
739.3M
Shs Float
223.29M
-
-
-
-
Target Price
-
52W Range
1.4-2.91
52W High
+32.5%
52W Low
+165%
RSI
57
Rel Volume
2.98
Avg Volume
172.05K
Volume
513K
Perf Week
4.33%
Perf Month
3.11%
Perf Quarter
-5.69%
Perf Half Y
1.15%
-
-
-
-
Beta
-0.203453
-
-
Volatility
0.04%, 0.06%
Prev Close
1.53%
Price
2.65
Change
1.92%
6896.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.94 | 1.08 | 0.88 | 1.11 | 1.34 | |
| Net income per share | 0.14 | 0.23 | 0.21 | 0.25 | 0.38 | |
| Operating cash flow per share | 0.26 | 0.29 | 0.23 | 0.22 | 0.37 | |
| Free cash flow per share | 0.09 | 0.12 | 0.11 | 0.15 | 0.35 | |
| Cash per share | 0.86 | 0.78 | 0.95 | 1.09 | 1.25 | |
| Book value per share | 1.43 | 1.56 | 1.65 | 1.85 | 2.08 | |
| Tangible book value per share | 1.43 | 1.56 | 1.65 | 1.85 | 2.08 | |
| Share holders equity per share | 1.43 | 1.56 | 1.65 | 1.85 | 2.08 | |
| Interest debt per share | 0.3 | 0.14 | 0.22 | 0.33 | 0.38 | |
| Market cap | 811.13M | 784.69M | 826.33M | 953.34M | 1.26B | |
| Enterprise value | 272.94M | 303.48M | 273.24M | 465.5M | 636.47M | |
| P/E ratio | 7.94 | 4.68 | 5.36 | 5.08 | 4.48 | |
| Price to sales ratio | 1.17 | 0.98 | 1.28 | 1.16 | 1.27 | |
| POCF ratio | 4.29 | 3.64 | 4.93 | 5.78 | 4.64 | |
| PFCF ratio | 12.03 | 9.1 | 9.86 | 8.8 | 4.93 | |
| P/B Ratio | 0.77 | 0.68 | 0.68 | 0.7 | 0.82 | |
| PTB ratio | 0.77 | 0.68 | 0.68 | 0.7 | 0.82 | |
| EV to sales | 0.39 | 0.38 | 0.42 | 0.57 | 0.64 | |
| Enterprise value over EBITDA | 1.73 | 1.27 | 1.36 | 1.67 | 1.51 | |
| EV to operating cash flow | 1.44 | 1.41 | 1.63 | 2.82 | 2.35 | |
| EV to free cash flow | 4.05 | 3.52 | 3.26 | 4.3 | 2.49 | |
| Earnings yield | 0.13 | 0.21 | 0.19 | 0.2 | 0.22 | |
| Free cash flow yield | 0.08 | 0.11 | 0.1 | 0.11 | 0.2 | |
| Debt to equity | 0.2 | 0.08 | 0.12 | 0.17 | 0.18 | |
| Debt to assets | 0.14 | 0.06 | 0.09 | 0.12 | 0.12 | |
| Net debt to EBITDA | -3.42 | -2.02 | -2.76 | -1.75 | -1.47 | |
| Current ratio | 2.83 | 2.46 | 2.51 | 2.48 | 2.44 | |
| Interest coverage | 29.25 | 23.33 | 14.67 | 30.29 | 37.31 | |
| Income quality | 1.27 | 0.98 | 0.88 | 0.7 | 0.72 | |
| Dividend Yield | 0.09 | 0.1 | 0.09 | 0.04 | 0.09 | |
| Payout ratio | 0.73 | 0.47 | 0.5 | 0.2 | 0.4 | |
| Sales general and administrative to revenue | 0.09 | 0.1 | 0.13 | 0.13 | 0.08 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.64 | -0.6 | -0.5 | -0.34 | -0.06 | |
| Capex to revenue | -0.18 | -0.16 | -0.13 | -0.07 | -0.02 | |
| Capex to depreciation | -19.26 | -13.6 | -2.63 | -1.53 | -0.41 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.11 | 2.82 | 2.78 | 3.25 | 4.22 | |
| ROIC | 0.08 | 0.14 | 0.1 | 0.12 | 0.16 | |
| Return on tangible assets | 0.07 | 0.1 | 0.09 | 0.1 | 0.12 | |
| Graham Net | 0.31 | 0.17 | 0.35 | 0.33 | 0.25 | |
| Working capital | 758.44M | 676.96M | 696.36M | 855.68M | 1.06B | |
| Tangible asset value | 1.06B | 1.15B | 1.22B | 1.37B | 1.54B | |
| Net current asset value | 744.03M | 666.98M | 691.46M | 846.86M | 1.03B | |
| Invested capital | 0.2 | 0.08 | 0.12 | 0.17 | 0.18 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 27.71M | 24.84M | 15.65M | 18.96M | 23.57M | |
| Average inventory | 45.22M | 41.75M | 37.67M | 51.9M | 55.63M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 70.79 | 27.95 | 34.27 | 32.81 | 34.08 | |
| Days of inventory on hand | 96.56 | 67.04 | 82.77 | 97.66 | 62.34 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 5.16 | 13.06 | 10.65 | 11.12 | 10.71 | |
| Inventory turnover | 3.78 | 5.44 | 4.41 | 3.74 | 5.86 | |
| ROE | 0.1 | 0.15 | 0.13 | 0.14 | 0.18 | |
| Capex per share | -0.16 | -0.17 | -0.11 | -0.08 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | -553.09M | -437.28M | -487.84M | -525.77M | -622.93M | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.26 | 0.17 | 0.17 | 0.23 | 0.18 | |
| Debt to assets | 0.19 | 0.12 | 0.12 | 0.17 | 0.12 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 2.51 | 2.45 | 2.48 | 2.59 | 2.44 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 696.36M | 728.73M | 855.68M | 809.8M | 1.06B | |
| Tangible asset value | 1.22B | 1.26B | 1.37B | 1.31B | 1.54B | |
| Net current asset value | 691.46M | 727.65M | 846.86M | 808.79M | 1.03B | |
| Invested capital | 0.26 | 0.17 | 0.17 | 0.23 | 0.18 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
6896.HK Frequently Asked Questions
What is Golden Throat Holdings Group Company Limited stock symbol ?
Golden Throat Holdings Group Company Limited is a CN stock and trading under the symbol 6896.HK
What is Golden Throat Holdings Group Company Limited stock quote today ?
Golden Throat Holdings Group Company Limited stock price is $2.65 today.
Is Golden Throat Holdings Group Company Limited stock public?
Yes, Golden Throat Holdings Group Company Limited is a publicly traded company.
Company Profile
- Volume Average 172.05K
- Market Capitalization 1.88B
- Employee 860
- CEO Mr. Yong Zeng
- Headquarters Liuzhou,CN
- IPO Date 2015-07-15
-
Website
https://www.goldenthroat.com 
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
